TEVA really needs to partner with MNTA for biosimilars. If FDA didn't spoon feed TEVA on characterizing enox, TEVA would never have got it approved. Teva would have got epipen approved long time ago with MNTA's characterization techniques.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.